Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanna Jacobus

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Contemporary Clinical Trials Communications|April 27, 2018
Decision on performing interim analysis for comparative clinical trialsKyongsun Pak, Susanna Jacobus, Hajime Uno
Pharmacoepidemiology and Drug Safety|September 24, 2004
Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitorsSusanna Jacobus, Sebastian Schneeweiss, K Arnold Chan
Clinical Genitourinary Cancer|January 2, 2017
Prognostic Significance of Increases in Hemoglobin in Renal Cell Carcinoma Patients During Treatment With VEGF-directed TherapyAbhishek Tripathi, Susanna Jacobus, Hope Feldman, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
Capecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinomaAndrea Bullock, Keith Stuart, Susanna Jacobus, et al.
Urology|November 28, 2008
Absence of relationship between steroid hormone levels and prostate cancer tumor gradeDavid J Sher, Christos Mantzoros, Susanna Jacobus, et al.
The Prostate|July 23, 2008
Relationship between serum adiponectin and prostate cancer gradeDavid J Sher, William K Oh, Susanna Jacobus, et al.
Cancer|February 28, 2009
The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93Robert A Kyle, Susanna Jacobus, William R Friedenberg, et al.
Leukemia Research|February 27, 2009
Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): a trial of the Eastern Cooperative Oncology GroupMartha Q Lacy, Susanna Jacobus, Emily A Blood, et al.
BJU International|October 30, 2009
Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancerMari Nakabayashi, William K Oh, Susanna Jacobus, et al.
Blood|July 10, 2015
Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myelomaA Keith Stewart, Susanna Jacobus, Rafael Fonseca, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Contemporary Clinical Trials Communications|April 27, 2018
Decision on performing interim analysis for comparative clinical trialsKyongsun Pak, Susanna Jacobus, Hajime Uno
Pharmacoepidemiology and Drug Safety|September 24, 2004
Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitorsSusanna Jacobus, Sebastian Schneeweiss, K Arnold Chan
Clinical Genitourinary Cancer|January 2, 2017
Prognostic Significance of Increases in Hemoglobin in Renal Cell Carcinoma Patients During Treatment With VEGF-directed TherapyAbhishek Tripathi, Susanna Jacobus, Hope Feldman, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
Capecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinomaAndrea Bullock, Keith Stuart, Susanna Jacobus, et al.
Urology|November 28, 2008
Absence of relationship between steroid hormone levels and prostate cancer tumor gradeDavid J Sher, Christos Mantzoros, Susanna Jacobus, et al.
The Prostate|July 23, 2008
Relationship between serum adiponectin and prostate cancer gradeDavid J Sher, William K Oh, Susanna Jacobus, et al.
Cancer|February 28, 2009
The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93Robert A Kyle, Susanna Jacobus, William R Friedenberg, et al.
Leukemia Research|February 27, 2009
Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): a trial of the Eastern Cooperative Oncology GroupMartha Q Lacy, Susanna Jacobus, Emily A Blood, et al.
BJU International|October 30, 2009
Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancerMari Nakabayashi, William K Oh, Susanna Jacobus, et al.
Blood|July 10, 2015
Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myelomaA Keith Stewart, Susanna Jacobus, Rafael Fonseca, et al.
Pageof 3